Eye Drops Recalled: Travoprost Missing Tamper Evidence Seal
Golden State Medical Supply is recalling Travoprost eye drops due to missing tamper evidence seals on some bottles. The missing seal prevents sterility assurance on 1,920 units distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for missing tamper evidence seal on an ophthalmic solution creates risk of sterility compromise. No illnesses or injuries have been reported, making this a risk-of-harm situation without confirmed adverse events.
Plain-English summary
Travoprost Ophthalmic Solution, USP 0.004% is a prescription eye medication manufactured by Golden State Medical Supply Inc. and Apotex Inc. The company is recalling specific lots due to a manufacturing defect.
The recalled products have missing tamper evidence seals on the secondary container. This defect prevents assurance that the medication meets required sterility standards, which is critical for products applied directly to the eye.
The recall affects 1,920 bottles distributed nationwide with the following affected lot numbers: GS049666 and GS049807 (expiring March 31, 2024) and GS049667 and GS051447 (expiring September 30, 2024). The affected products are available in 2.5 mL bottles (NDC 51407-731-25) and 5 mL bottles (NDC 51407-731-05).
Patients currently using medication from the affected lots should contact their pharmacist or healthcare provider immediately. Do not continue use of any bottles with missing or damaged tamper evidence seals.
The recalled product
- Product
- TRAVOPROST (TRAVOPROST)
- Brand
- TRAVOPROST
- Manufacturer
- Golden State Medical Supply Inc.
- Category
- Drug — Ophthalmic
- Affected units
- 1,920
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #s: a) GS049666
- GS049807
- Exp: 03/31/2024
- b) GS049667
- GS051447
- Exp: 09/30/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TRAVOPROST
- ModerateCardinal Health Recalls Travoprost Ophthalmic Solution Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
Same manufacturer · Golden State Medical Supply Inc.
See all →- SevereGolden State Medical Supply Recalls Prasugrel Tablets for Failed Dissolution
FDA (Drugs) · 2026-09-09
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
Similar recalls
- HighPar Pharmaceutical Recalls Travoprost Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-12-07
- HighPrescription Eye Drop Medication Recalled for Subpotency and Contamination
FDA (Drugs) · 2022-04-13
- HighTRP Eye Strain Relief Eye Drops Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2024-03-20
- HighEye Drops Recall: TRP Eye Twitching Relief Lacks Sterility Assurance
FDA (Drugs) · 2024-03-20
- HighTRP Blur Relief Eye Drops Recalled Nationwide for Sterility Assurance Failure
FDA (Drugs) · 2024-03-20
- HighGlaucoma eye drops recalled over sterility assurance and bottle sealing concerns
FDA (Drugs) · 2025-10-08